SARS-CoV-2-specific CD4


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
21 11 2022
Historique:
received: 21 07 2022
accepted: 13 11 2022
pubmed: 22 11 2022
medline: 11 1 2023
entrez: 21 11 2022
Statut: epublish

Résumé

Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific CD4

Identifiants

pubmed: 36408799
doi: 10.7554/eLife.82050
pii: 82050
pmc: PMC9822249
doi:
pii:

Substances chimiques

Receptors, Antigen, T-Cell 0

Banques de données

NTR
['NL8589']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2022, Pothast et al.

Déclaration de conflit d'intérêts

CP, RD, MT, RH, MK, AW, PH, Mv, SG, JF, MH No competing interests declared

Auteurs

Cilia R Pothast (CR)

Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.

Romy C Dijkland (RC)

Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.

Melissa Thaler (M)

Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands.

Renate S Hagedoorn (RS)

Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.

Michel G D Kester (MGD)

Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.

Anne K Wouters (AK)

Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.

Pieter S Hiemstra (PS)

Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands.

Martijn J van Hemert (MJ)

Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands.

Stephanie Gras (S)

Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Victoria, Australia.
Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.

J H Frederik Falkenburg (JHF)

Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.

Mirjam H M Heemskerk (MHM)

Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH